Equillium, Inc. financial data

Symbol
EQ on Nasdaq
Industry
Pharmaceutical Preparations
Location
2223 Avenida De La Playa, Suite 105, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 239 % +17.1%
Debt-to-equity 70.8 % -45.3%
Return On Equity -37.6 % +27.4%
Return On Assets -22 % +2.44%
Operating Margin -20.1 % +50%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.6M shares +1.01%
Common Stock, Shares, Outstanding 35.6M shares +0.86%
Entity Public Float 15.4M USD -3.75%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.4M shares +1.82%
Weighted Average Number of Shares Outstanding, Diluted 35.4M shares +1.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 41.1M USD +13.9%
General and Administrative Expense 11.9M USD -12%
Operating Income (Loss) -8.27M USD +43.1%
Nonoperating Income (Expense) 57K USD -75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.6M USD +59.8%
Income Tax Expense (Benefit) 361K USD -37.8%
Net Income (Loss) Attributable to Parent -8.07M USD +39.5%
Earnings Per Share, Basic -0.23 USD/shares +39.5%
Earnings Per Share, Diluted -0.23 USD/shares +39.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.1M USD -22.1%
Cash, Cash Equivalents, and Short-term Investments 22.6M USD -44.7%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 429K USD +82.6%
Assets, Current 25M USD -49.4%
Property, Plant and Equipment, Net 262K USD -16.8%
Operating Lease, Right-of-Use Asset 364K USD -54.3%
Other Assets, Noncurrent 45K USD -43%
Assets 25.6M USD -49.3%
Accounts Payable, Current 2.68M USD -43.1%
Employee-related Liabilities, Current 437K USD -85.7%
Accrued Liabilities, Current 3.48M USD -48%
Liabilities, Current 6.36M USD -76.9%
Operating Lease, Liability, Noncurrent 187K USD -51.3%
Liabilities 6.54M USD -76.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 781K USD +458%
Retained Earnings (Accumulated Deficit) -194M USD -4.34%
Stockholders' Equity Attributable to Parent 19.1M USD -15.6%
Liabilities and Equity 25.6M USD -49.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.8M USD -10.1%
Net Cash Provided by (Used in) Financing Activities -1.43M USD
Net Cash Provided by (Used in) Investing Activities -2.83M USD +88.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 35.6M shares +0.86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.6M USD +66.3%
Deferred Tax Assets, Valuation Allowance 50.9M USD +7.88%
Deferred Tax Assets, Gross 51.1M USD +7.62%
Operating Lease, Liability 384K USD -53.4%
Depreciation 32K USD +3.23%
Payments to Acquire Property, Plant, and Equipment 19K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.43M USD +44%
Lessee, Operating Lease, Liability, to be Paid 416K USD -54.2%
Operating Lease, Liability, Current 197K USD -55.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169K USD -22.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 219K USD -55.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32K USD -61.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28K USD -83.4%
Deferred Tax Assets, Operating Loss Carryforwards 27.5M USD +40.8%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.92M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 28K USD -83.4%
Operating Lease, Payments 122K USD -26.9%
Deferred Tax Assets, Net of Valuation Allowance 124K USD -45.6%
Share-based Payment Arrangement, Expense 3.75M USD -6.18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%